|
1
|
Zhao F, Li M, Kong L, Zhang G and Yu J:
Delineation of radiation therapy target volumes for patients with
postoperative glioblastoma: A review. Onco Targets Ther.
9:3197–3204. 2016.PubMed/NCBI
|
|
2
|
Koekkoek JA, Kerkhof M, Dirven L, Heimans
JJ, Reijneveld JC and Taphoorn MJ: Seizure outcome after
radiotherapy and chemotherapy in low-grade glioma patients: A
systematic review. Neuro Oncol. 17:924–934. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bradshaw A, Wickremsekera A, Tan ST, Peng
L, Davis PF and Itinteang T: Cancer stem cell hierarchy in
glioblastoma multiforme. Front Surg. 3:212016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Neagu MR and Reardon DA: An update on the
role of immunotherapy and vaccine strategies for primary brain
tumors. Curr Treat Options Oncol. 16:542015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li X, Nie J, Mei Q and Han WD: MicroRNAs:
Novel immunotherapeutic targets in colorectal carcinoma. World J
Gastroenterol. 22:5317–5331. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Diab M, Muqbil I, Mohammad RM, Azmi AS and
Philip PA: The role of microRNAs in the diagnosis and treatment of
pancreatic adenocarcinoma. J Clin Med. 5(pii): E592016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song H, Rao Y, Zhang G and Kong X:
MicroRNA-384 inhibits the growth and invasion of renal cell
carcinoma cells by targeting astrocyte elevated gene 1. Oncol Res.
Aug 25–2017.(Epub ahead of print).
|
|
8
|
Anninos P, Chatzimichael A, Adamopoulos A,
Kotini A and Tsagas N: A combined study of MEG and pico-Tesla TMS
on children with autism disorder. J Integr Neurosci. 15:497–513.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X, Qi G, Zhang J, Wu J, Zhou N, Li L
and Ma J: Knockdown of long noncoding RNA small nucleolar RNA host
gene 12 inhibits cell growth and induces apoptosis by upregulating
miR-138 in nonsmall cell lung cancer. DNA Cell Biol. 36:892–900.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang N, Zhang Y and Liang H: microRNA-598
inhibits cell proliferation and invasion of glioblastoma by
directly targeting metastasis associated in colon cancer-1. Oncol
Res. Feb 14–2018.(Epub ahead of print). View Article : Google Scholar
|
|
11
|
Hamam R, Hamam D, Alsaleh KA, Kassem M,
Zaher W, Alfayez M, Aldahmash A and Alajez NM: Circulating
microRNAs in breast cancer: Novel diagnostic and prognostic
biomarkers. Cell Death Dis. 8:e30452017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ren J, Yang Y, Xue J, Xi Z, Hu L, Pan SJ
and Sun Q: Long noncoding RNA SNHG7 promotes the progression and
growth of glioblastoma via inhibition of miR-5095. Biochem Biophys
Res Commun. 496:712–718. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi H, Ji Y, Zhang D, Liu Y and Fang P:
MicroRNA-3666-induced suppression of SIRT7 inhibits the growth of
non-small cell lung cancer cells. Oncol Rep. 36:3051–3057. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang G, Cai C and Chen L: MicroRNA-3666
regulates thyroid carcinoma cell proliferation via MET. Cell
Physiol Biochem. 38:1030–1039. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Duan J, Zhou K, Tang X, Duan J and Zhao L:
MicroRNA-34a inhibits cell proliferation and induces cell apoptosis
of glioma cells via targeting of Bcl-2. Mol Med Rep. 14:432–438.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hua S, Liu C, Liu L and Wu D: miR-142-3p
inhibits aerobic glycolysis and cell proliferation in
hepatocellular carcinoma via targeting LDHA. Biochem Biophys Res
Commun. 496:947–954. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Y, Chen X, Cheng R, Yang F, Yu M, Wang
C, Cui S, Hong Y, Liang H, Liu M, et al: The Jun/miR-22/HuR
regulatory axis contributes to tumourigenesis in colorectal cancer.
Mol Cancer. 17:112018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun G, SiMa G, Wu C, Fan Y, Tan Y, Wang Z,
Cheng G and Li J: Decreased MiR-17 in glioma cells increased cell
viability and migration by increasing the expression of Cyclin D1,
p-Akt and Akt. PLoS One. 13:e01905152018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Utaijaratrasmi P, Vaeteewoottacharn K,
Tsunematsu T, Jamjantra P, Wongkham S, Pairojkul C, Khuntikeo N,
Ishimaru N, Sirivatanauksorn Y, Pongpaibul A, et al: The
microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated
fibroblasts promotes migration of cancer cells. Mol Cancer.
17:102018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tahiri A, Aure MR and Kristensen VN:
MicroRNA networks in breast cancer cells. Methods Mol Biol.
1711:55–81. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu G, Fu D, Jia C, Chai L, Han Y, Liu J,
Wu T, Xie R, Chang Z, Yang H, et al: Reduced miR-105-1 levels are
associated with poor survival of patients with non-small cell lung
cancer. Oncol Lett. 14:7842–7848. 2017.PubMed/NCBI
|
|
23
|
Mei LL, Qiu YT, Wang WJ, Bai J and Shi ZZ:
Overexpression of microRNA-1470 promotes proliferation and
migration, and inhibits senescence of esophageal squamous carcinoma
cells. Oncol. Lett. 14:7753–7758. 2017.
|
|
24
|
Yang H, Wang L, Tang X and Bai W: miR-203a
suppresses cell proliferation by targeting E2F transcription factor
3 in human gastric cancer. Oncol Lett. 14:7687–7690.
2017.PubMed/NCBI
|
|
25
|
Kan Q, Su Y and Yang H: MicroRNA-335 is
downregulated in papillary thyroid cancer and suppresses cancer
cell growth, migration and invasion by directly targeting ZEB2.
Oncol Lett. 14:7622–7628. 2017.PubMed/NCBI
|
|
26
|
Hu B, Wang J and Jin X: MicroRNA-138
suppresses cell proliferation and invasion of renal cell carcinoma
by directly targeting SOX9. Oncol Lett. 14:7583–7588.
2017.PubMed/NCBI
|
|
27
|
Zhang G, Chen L, Khan AA, Li B, Gu B, Lin
F, Su X and Yan J: miRNA-124-3p/neuropilin-1 (NRP-1) axis plays an
important role in mediating glioblastoma growth and angiogenesis.
Int J Cancer. 143:635–644. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen W, Kong KK, Xu XK, Chen C, Li H, Wang
FY, Peng XF, Zhang Z, Li P, Li JL and Li FC: Downregulation of
miR-205 is associated with glioblastoma cell migration, invasion,
and the epithelial-mesenchymal transition, by targeting ZEB1 via
the Akt/mTOR signaling pathway. Int J Oncol. 52:485–495.
2018.PubMed/NCBI
|
|
29
|
Kong Y, Zou S, Yang F, Xu X, Bu W, Jia J
and Liu Z: RUNX3-mediated up-regulation of miR-29b suppresses the
proliferation and migration of gastric cancer cells by targeting
KDM2A. Cancer Lett. 381:138–148. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen JY, Luo CW, Lai YS, Wu CC and Hung
WC: Lysine demethylase KDM2A inhibits TET2 to promote DNA
methylation and silencing of tumor suppressor genes in breast
cancer. Oncogenesis. 6:e3692017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang Y, Liu Y, Yu L, Chen J, Hou J, Cui
L, Ma D and Lu W: Histone demethylase KDM2A promotes tumor cell
growth and migration in gastric cancer. Tumour Biol. 36:271–278.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wagner KW, Alam H, Dhar SS, Giri U, Li N,
Wei Y, Giri D, Cascone T, Kim JH, Ye Y, et al: KDM2A promotes lung
tumorigenesis by epigenetically enhancing ERK1/2 signaling. J Clin
Invest. 123:5231–5246. 2013. View
Article : Google Scholar : PubMed/NCBI
|
